| Hospice Buffalo Inc 225 Como Park Blvd, Cheektowaga, NY, 14227 | |
| (716) 686-1900 |
News Archive
The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Thomas Jefferson University Hospitals selected MedeAnalytics' ICD-10 Intelligence and Compliance and Revenue Integrity solutions to support their efforts pertaining to coding efficiency, corporate compliance, and risk assessment.
› Verified 7 days ago
| Name | Hospice Buffalo Inc |
|---|---|
| Location | 225 Como Park Blvd, Cheektowaga, New York |
| Hospice ID | 331502 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 240 |
News Archive
The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Thomas Jefferson University Hospitals selected MedeAnalytics' ICD-10 Intelligence and Compliance and Revenue Integrity solutions to support their efforts pertaining to coding efficiency, corporate compliance, and risk assessment.
› Verified 7 days ago
| NPI Number | 1447241088 |
| Organization Name | Hospice Buffalo, Inc. |
| Address | 225 Como Park Blvd Cheektowaga, New York, 14227 |
| Phone Number | (716)686-1900 |
News Archive
The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Thomas Jefferson University Hospitals selected MedeAnalytics' ICD-10 Intelligence and Compliance and Revenue Integrity solutions to support their efforts pertaining to coding efficiency, corporate compliance, and risk assessment.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 80.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 83.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 88.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 97.4 | 93.3 |
News Archive
The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Thomas Jefferson University Hospitals selected MedeAnalytics' ICD-10 Intelligence and Compliance and Revenue Integrity solutions to support their efforts pertaining to coding efficiency, corporate compliance, and risk assessment.
› Verified 7 days ago
| Home Health Aides | 51.4 |
| Counselors | 9 |
| Licensed Practical or Vocational Nurses | 14.2 |
| Medical Social Workers | 26.2 |
| Physicians | 8 |
| Registered Nurses | 161.3 |
| Other Personnel | 9.9 |
| Total Employees | 280 |
|---|
News Archive
The often feared and sometimes deadly infections caused by MRSA - methicillin-resistant Staphylococcus aureus - are now moving out of hospitals and emerging as an even more virulent strain in community settings and on athletic teams, and raising new concerns about antibiotic resistance.
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Thomas Jefferson University Hospitals selected MedeAnalytics' ICD-10 Intelligence and Compliance and Revenue Integrity solutions to support their efforts pertaining to coding efficiency, corporate compliance, and risk assessment.
› Verified 7 days ago
| Hospice Buffalo Inc Location: 225 Como Park Blvd, Cheektowaga, New York, 14227 Phone: (716) 686-1900 |